Swisspharma Polskasp. z o.o.
Manufacture of other food products not elsewhere classified
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2021 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 1131 days for 2018).
- 2021not filed
- 202007/10/2022
- 201919/08/2022
- 201819/08/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2020.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 99 | $1,337.12 | 99% | |
Others | 1 | $13.51 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2022-09-01 to 2024-06-06.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $6,784.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $429$429 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $429$429 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 19, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,539$5,539 | Polski Fundusz Rozwoju S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nikalabsp. z o.o. | $2,614,050.94 | nikalab.pl | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com | ||
| Zojo. The Gorgeousness Companysp. z o.o. | $358,480.80 | zojoelixirs.com | ||
| VEGG Whitesp. z o.o. | $282,669.16 | vegg-white.com | ||
| Green Worldsp. z o.o. | $122,769.66 | en.world-food.com | ||
| Cannabis PolandS.A. | $55,015.30 | cannabispolandsa.com | ||
| Bulagosp. z o.o. | $44,002.93 | kavaha.pl | ||
| Proteinrisesp. z o.o. | $46,108.13 | proteinrise.com | ||
| Genezyxsp. z o.o. | $6,335.82 | genezyx.com |
Change history
| Date | Event | |
|---|---|---|
| 2018-07-23 | Address change (Aleja Bohaterów Września 3/8, 02-389, Warszawa → Aleje Jerozolimskie 155/U3, 02-326, Warszawa) | |
| 2018-01-09 | Entered in the register |
FAQ
Last updated: 2026-04-27